<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03211169</url>
  </required_header>
  <id_info>
    <org_study_id>40988</org_study_id>
    <nct_id>NCT03211169</nct_id>
  </id_info>
  <brief_title>Comparison Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies in Biliary Strictures</brief_title>
  <official_title>Comparative Efficacy of Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies for Obtaining Diagnostic Tissue From Indeterminate Biliary Strictures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, randomized, multi-center study. Investigators will compare diagnostic yield of
      bile duct brushings, pediatric biopsy forceps biopsies and cholangioscopy-directed biopsies
      for obtaining diagnostic tissue from biliary strictures.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 29, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized prospective study</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic tissue obtained as assessed by histologic evaluation of biopsy specimen</measure>
    <time_frame>1 week</time_frame>
    <description>Malignancy or no malignancy diagnosis obtained from stricture biopsy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost</measure>
    <time_frame>2 years</time_frame>
    <description>Cumulative $ from devices used and facility fees with each approach</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation Exposure</measure>
    <time_frame>2 years</time_frame>
    <description>Total Dose, Fluoroscopy Time, Dose Area Product, Effective dose per fluoroscopy machine readings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure Duration</measure>
    <time_frame>2 years</time_frame>
    <description>in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Latency to diagnosis</measure>
    <time_frame>2 years</time_frame>
    <description>Duration in days from initial procedure to diagnosis of benign or malignant stricture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>2 weeks</time_frame>
    <description>(Pancreatitis, Bleeding, Infection, Perforation, Death to be assessed one day, one week post-procedure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cholangiocarcinoma</condition>
  <condition>Stricture; Bile Duct</condition>
  <arm_group>
    <arm_group_label>Pediatric Biopsy Forceps directed biopsies</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biopsies of the stricture will be taken with Pediatric Biopsy Forceps after bile duct brushings have been obtained.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cholangioscopy-directed biopsies</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Biopsies of the stricture will be taken under cholangioscopic guidance after bile duct brushings have been obtained.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsies of bile duct stricture with pediatric biopsy forceps</intervention_name>
    <description>Biopsies of the stricture will be taken to evaluate diagnostic yield of Pediatric Biopsy Forceps</description>
    <arm_group_label>Pediatric Biopsy Forceps directed biopsies</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsies of bile duct stricture with cholangioscopy-directed biopsies</intervention_name>
    <description>Biopsies of the stricture will be taken to evaluate diagnostic yield of cholangioscopy-directed biopsies</description>
    <arm_group_label>Cholangioscopy-directed biopsies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. All patients with obstructive jaundice, and imaging (CT or MRI) suggestive of biliary
             stricture, without obvious pancreatic mass

          2. All patients with obstructive jaundice, and index ERCP suggestive of biliary
             stricture, without obvious pancreatic mass

          3. All patients with obstructive jaundice, and prior ERCP suggestive of biliary stricture

          4. Expected patient survival of at least 90 days

          5. High likelihood of patient follow-up

          6. Patient is able to give a written informed consent

          7. Patient is willing and able to comply with the study procedures

        Exclusion Criteria:

          1. Patients with imaging suggestive of pancreatic tumor

          2. Children &lt; 18 years of age

          3. Pregnant women

          4. Patients with impaired decision-making

          5. Healthy volunteers

          6. Primary Sclerosing Cholangitis (PSC)

          7. Patients with untreated coagulopathy at the time of procedure or ongoing need for
             anti-coagulation

          8. Patients with any contraindication to endoscopic procedure

          9. Participation in another investigational study that may directly or indirectly affect
             the results of this study within 30 days prior to the initial visit

         10. Patients unable to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Subhas Banerjee, MD</last_name>
    <phone>650-723-2623</phone>
    <email>sbanerje@stanford.edu</email>
  </overall_contact>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2017</study_first_submitted>
  <study_first_submitted_qc>July 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2017</study_first_posted>
  <last_update_submitted>July 28, 2017</last_update_submitted>
  <last_update_submitted_qc>July 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Subhas Banerjee</investigator_full_name>
    <investigator_title>Associate Professor of Medicine, Division of Gastroenterology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

